Bay Street News, January, 2025

VANCOUVER, British Columbia, Jan. 10, 2025 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (“ZenaTech”), a technology company specializing […]

2024 Portfolio Receipts expected to be approximately $2,800 million, at the upper end of guidance range Exciting development-stage pipeline with […]

VANCOUVER, Wash. and PARIS, Jan. 10, 2025 (GLOBE NEWSWIRE) — Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation […]

LOUISVILLE, Ky., Jan. 10, 2025 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (“CDI” or “the Company”) announced today that the Company […]

NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) — Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing […]

HOUSTON, TX, Jan. 10, 2025 (GLOBE NEWSWIRE) — Prairie Operating Co. (Nasdaq: PROP) (the “Company” or “Prairie”) today announced the […]

Royalty Pharma plc to become an integrated company by acquiring its external manager, RP Management, LLC Significant annual cash savings […]

SEATTLE, Jan. 10, 2025 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company […]

ORLANDO, Fla., Jan. 10, 2025 (GLOBE NEWSWIRE) — Gencor Industries, Inc. (the “Company”) (NYSE American: GENC) announced that on January […]

CHICAGO and VANCOUVER, British Columbia, Jan. 10, 2025 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (“Green Thumb” or the “Company”) […]